BRC [BRCC] vs Bioharvest Sciences [BHST] Detailed Stock Comparison

BRC Inc.

NYSE
Loading...

Bioharvest Sciences Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: BRC Inc. wins in 13 metrics, Bioharvest Sciences Inc. wins in 6 metrics, with 0 ties. BRC Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric BRC Inc. Bioharvest Sciences Inc. Better
P/E Ratio (TTM) -8.38 -7.30 Bioharvest Sciences Inc.
Price-to-Book Ratio 2.72 3.90 BRC Inc.
Debt-to-Equity Ratio 91.21 55.42 Bioharvest Sciences Inc.
PEG Ratio 36.00 -51.53 BRC Inc.
EV/EBITDA -17.93 -17.68 Bioharvest Sciences Inc.
Profit Margin (TTM) -2.99% -32.27% BRC Inc.
Operating Margin (TTM) -2.08% -12.37% BRC Inc.
Return on Equity -54.86% -83.17% BRC Inc.
Return on Assets (TTM) -4.65% -9.59% BRC Inc.
Free Cash Flow (TTM) $-13.47M $-9.58M Bioharvest Sciences Inc.
1-Year Return -8.38% -38.34% BRC Inc.
Price-to-Sales Ratio (TTM) 0.32 2.88 BRC Inc.
Enterprise Value $204.49M $90.35M BRC Inc.
EV/Revenue Ratio 0.51 2.62 BRC Inc.
Gross Profit Margin (TTM) 32.07% 57.63% Bioharvest Sciences Inc.
Revenue per Share (TTM) $4 $2 BRC Inc.
Earnings per Share (Diluted) $-0.13 $-0.60 BRC Inc.
Beta (Stock Volatility) 0.76 1.40 BRC Inc.
Short % of Float 10.26% 0.34% Bioharvest Sciences Inc.

BRC Inc. vs Bioharvest Sciences Inc. Stock Performance Analysis

Loading Price Chart...

BRCC
BHST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
BRC Inc.-3.85%-12.79%37.61%85.19%14.50%33.93%
Bioharvest Sciences Inc.-1.66%-9.18%-14.01%-19.09%-45.40%-31.67%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
BRC Inc.-8.38%-70.13%-89.93%-89.93%-89.93%-89.93%
Bioharvest Sciences Inc.-38.34%-35.67%-35.67%-35.67%-35.67%-35.67%

Performance & Financial Health Analysis: BRC Inc. vs Bioharvest Sciences Inc.

MetricBRCCBHST
Market Information
Market Cap i$129.29M$99.29M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i428,38414,610
90 Day Avg. Volume i526,54523,620
Last Close$1.50$3.56
52 Week Range$0.60 - $2.10$3.54 - $12.80
% from 52W High-28.57%-72.19%
All-Time High$34.00 (Apr 11, 2022)$12.80 (Oct 07, 2025)
% from All-Time High-95.59%-72.19%
Growth Metrics
Quarterly Revenue Growth0.07%0.25%
Quarterly Earnings Growth0.06%0.25%
Financial Health
Profit Margin (TTM) i-0.03%-0.32%
Operating Margin (TTM) i-0.02%-0.12%
Return on Equity (TTM) i-0.55%-0.83%
Debt to Equity (MRQ) i91.2155.42
Cash & Liquidity
Book Value per Share (MRQ)$0.40$1.12
Cash per Share (MRQ)$0.04$1.02
Operating Cash Flow (TTM) i$-9,810,000$-7,226,000
Levered Free Cash Flow (TTM) i$-1,676,125$-10,782,250
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: BRC Inc. vs Bioharvest Sciences Inc.

MetricBRCC (Apr 24, 2026)BHST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-8.38-7.30
Forward P/E i36.00-51.53
PEG Ratio i36.00-51.53
Price to Sales (TTM) i0.322.88
Price to Book (MRQ) i2.723.90
Market Capitalization
Market Capitalization i$129.29M$99.29M
Enterprise Value i$204.49M$90.35M
Enterprise Value Metrics
Enterprise to Revenue i0.512.62
Enterprise to EBITDA i-17.93-17.68
Risk & Other Metrics
Beta i0.761.40
Book Value per Share (MRQ) i$0.40$1.12

Financial Statements Comparison: BRC Inc. vs Bioharvest Sciences Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBRCC (2025)BHST (2025)
Revenue/Sales i398.26M34.51M
Cost of Goods Sold i260.32M14.03M
COGS % of Revenue i65.4%40.7%
Gross Profit i137.95M20.48M
Gross Margin i34.6%59.3%
Research & Development iN/A5.31M
Operating Income (EBIT) i-24.60M-5.58M
Operating Margin i-6.2%-16.2%
EBITDA i-12.40M-4.88M
EBITDA Margin i-3.1%-14.1%
Pre-Tax Income i-32.10M-11.06M
Pre-Tax Income % of Revenue i-8.1%-32.0%
Income Tax i132,00076,000
Income Tax % of Revenue i0.0%0.2%
Net Income (Profit) i-32.24M-11.14M
Profit Margin i-8.1%-32.3%

Balance Sheet & Liquidity Metrics

MetricBRCC (2025)BHST (2025)
Cash & Equivalents i4.33M23.03M
Total Current Assets i100.33M30.50M
Total Current Assets % of Revenue i25.2%88.4%
Total Current Liabilities i76.09M7.68M
Total Current Liabilities % of Revenue i19.1%22.3%
Long-Term Debt i57.15M12.55M
Long-Term Debt % of Revenue i14.3%36.4%
Total Shareholders Equity i68.02M25.45M
Retained Earnings i-135.34M-107.55M
Retained Earnings % of Revenue i-34.0%-311.7%
Property, Plant & Equipment i21.21M830,000

Cash Flow Statement Comparison

MetricBRCC (2025)BHST (2025)
Operating Cash Flow i-29.12M-7.71M
Operating Cash Flow % of Revenue i-7.3%-22.3%
Capital Expenditures i1.42M-2.36M
Free Cash Flow i-13.47M-9.58M
FCF Margin i-3.4%-27.8%
Debt Repayment i-280.76M-7.15M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBRCCBHST
Shares Short i8.23M65,292
Short Ratio i8.402.41
Short % of Float i10.26%0.34%
Shares Outstanding i114.86M22.67M
Float Shares i71.21M17.82M
% Held by Insiders i23.70%16.60%
% Held by Institutions i58.03%8.28%
% Held by Public i18.27%75.12%

Dividend Analysis & Yield Comparison: BRC Inc. vs Bioharvest Sciences Inc.

MetricBRCCBHST
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A